http://archive.fast-edgar.com/20260713/AM22L22MZ22292M2222T22E2RUJ2KG223282
Filed on: July 13, 2026
Filed by Akzo Nobel N.V. Pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Axalta Coating Systems Ltd. (Commission File No.: 001-36733) Date: July 13, 2026
The following is a press release published by Akzo Nobel N.V. on July 13th, 2026:
Akzo Nobel N.V.
Media release
July 13, 2026
AkzoNobel confirms receiving offers... (continue reading...)
Filed Pursuant to Rule 424(b)(2)
Registration Statement No. 333-284538
The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to Completion. Dated July 13, 2026.
$
The Goldman Sachs Group, Inc.
Callable Fixed Rate... (continue reading...)
More SEC Filings
View Older Stories-
Form 487 FT 13099
-
Form 487 FT 13167
-
Form 10-Q Jubilant Flame Internati For: May 31
-
Form 487 FT 13166
-
Form 497 Rayliant Funds Trust
-
Form 424B2 UBS AG
-
Form 13F-HR Echo45 Advisors LLC For: Jun 30
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form POSASR Esperion Therapeutics,
-
Form D AlphaKeys ExodusPoint
-
Form D Dendrion Innoblative 1,
-
Form POS AM Esperion Therapeutics,
-
Form 424B2 ROYAL BANK OF CANADA
-
Form 424B2 MORGAN STANLEY
-
Form POS AM Esperion Therapeutics,
-
Form POS462B Esperion Therapeutics,
-
Form 4 Fundrise Income Real For: Jul 10 Filed by: Starr Gayle P
-
Form 4/A H2O AMERICA For: Jul 07 Filed by: ATLAS Infrastructure Partners (UK) Ltd.
-
Form 424B2 UBS AG
-
Form D FCP Venture X QP LLC,
-
Form 497 Tidal Trust III
-
Form D Series 18-4, a series
-
Form 497K EA Series Trust
-
Form POS AM Esperion Therapeutics,
-
Form F-6EF Amundi S.A./ADR Filed by: BANK OF NEW YORK / ADR DIVISION
-
Form 4 Texas Pacific Land Corp For: Jul 10 Filed by: HORIZON KINETICS ASSET MANAGEMENT LLC
-
Form POS AM Esperion Therapeutics,
-
Form 13F-HR DAVENPORT & Co LLC For: Jun 30
-
Form 6-K Mint Inc Ltd For: Jul 13
-
Form 424B2 UBS AG
-
Form 424B2 MORGAN STANLEY
-
Form D/A Institutional Drilling
-
Form POS AM Esperion Therapeutics,
-
Form N-PX Lindsell Train Ltd For: Jun 30
-
Form 497 EA Series Trust
-
Form CERT Shell Finance US Inc.
-
Form 424B2 MORGAN STANLEY
-
Form N-PX Intelligent Financial For: Jun 30
-
Form POS AM Esperion Therapeutics,
-
Form CERT Shell plc
-
Form FWP GOLDMAN SACHS GROUP INC Filed by: GOLDMAN SACHS GROUP INC
-
Form FWP GS Finance Corp. Filed by: GS Finance Corp.
-
Form 424B2 UBS AG
-
Form D MDHGEB5 LLC
-
Form N-CEN Peachtree Alternative For: Apr 30
-
Form S-8 POS Esperion Therapeutics,
-
Form 424B2 CITIGROUP INC
-
Form S-8 POS Esperion Therapeutics,
-
Form 4/A NorthWestern Energy Grou For: Jul 09 Filed by: YAZDI MAHVASH
-
Form 424B2 UBS AG

